Study S002645

A Randomized, Open-label, Crossover Study to Evaluate Relative Bioavailability, and Food Effect of HDM1002 in Healthy Subjects

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06608329
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: NONE
Status: UNKNOWN
Enrollment: 33
Start: 2024-10
Primary completion: 2024-11
Lead sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Conditions: Healthy Adult Subject
Interventions: DRUG:HDM1002
Results posted: FALSE

Registered primary outcomes

AUC[0-∞] [Day1-Day17]
AUC[0-t] [Day1-Day17]
Cmax [Day1-Day17]
Tmax [Day1-Day17]
t1/2 [Day1-Day17]
CL/F [Day1-Day17]
Vz/F [Day1-Day17]
F [Day1-Day17]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.